Navigation Links
Funding to tackle hospital superbugs

A novel approach to treating infectious diseases is being developed by researchers at Cardiff University.

Superbugs such as MRSA (Methicillin Resistant Staphylococcus Aureus) are resistant to one of more conventional antibiotic and require new therapies to aid the treatment of infection.

A team in the School of Medicine's Institute of Nephrology has been awarded £800,000 by the Wellcome Trust to commercially develop a protein based therapeutic to help treat infectious diseases.

Professor Nicholas Topley said: "Infectious diseases are a significant problem and the number of new antibiotics entering the market is falling rapidly whilst antibiotic resistance is increasing. The funding from the Wellcome Trust will help bring the pioneering new approaches developed in the School of Medicine to the market."

Research into the development of novel proteins discovered by the team led by Professor Topley and Dr Simon Jones has already identified new pathways that enhance the bodies natural defence mechanisms to promote the clearance of infection. The new approach has been named "Resolution Therapeutics" by the Cardiff researchers.

It is hoped that research in the School of Medicine will lead to the development of other drugs that modify host responses with the view to resolving infection and reducing inflammation in diseases such as arthritis.


Source:Cardiff University

Page: 1

Related biology news :

1. Funding and bureaucracy, not access to journals, are chief obstacles to scientific productivity
2. South Africa still debating how to tackle HIV/AIDS when 5 million are infected
3. Cancer cells suppress large regions of DNA by a reversible process that can be tackled
4. Smooth sailing: cruise ship virus tackled by UH, Baylor College of Medicine
5. Research project tackles regeneration gap
6. New antibacterials being developed to tackle MRSA superbug
7. New strategies to reduce hospital-aquired infections
8. Bacteria can survive for weeks on hospital surfaces
9. One in 14 men having a heart attack drive themselves to hospital
10. Minorities, uninsured less likely to receive care at high-volume hospitals
11. Controlling antibiotics and antibiotic resistance in hospitals
Post Your Comments:

(Date:10/29/2015)...   MedNet Solutions , an innovative SaaS-based eClinical ... research, is pleased to announce that it has been ... one of only three finalists for a 2015 ... Growing" category. The Tekne Awards honor Minnesota ... innovation and leadership. iMedNet™ eClinical ...
(Date:10/29/2015)... RESTON, Va. , Oct. 29, 2015 ... announced today that it has released a new version ... Daon customers in North America ... gains. IdentityX v4.0 also includes a FIDO UAF ... customers are already preparing to activate FIDO features. These ...
(Date:10/29/2015)... Oct. 29, 2015  Connected health pioneer, Joseph ... explosion of technology-enabled health and wellness, and the business ... The Internet of Healthy Things . ... smartphones even existed, Dr. Kvedar, vice president, Connected Health, ... care delivery, moving care from the hospital or doctor,s ...
Breaking Biology News(10 mins):
(Date:11/30/2015)... Partnership includes an MPP ... u niversity , s Solid Drug Nanoparticle (SDN) Technology ... - up through cost cuts of ... where licensees based anywhere in the world will have the right to make, use ... , where licensees based anywhere in the world will have the right to ...
(Date:11/30/2015)... , Nov. 30, 2015 Spherix Incorporated ... committed to the fostering and monetization of intellectual ... and prospective initiatives designed to create shareholder value. ... Officer of Spherix. "Based on published reports, the ... exceeds $50 billion and Spherix will seek to ...
(Date:11/30/2015)... 2015 TapImmune, Inc. (TPIV), ... innovative peptide and gene-based immunotherapeutics and vaccines for the ... will be presenting at the 8 th Annual ... 2.30 PM PT. Dr. John N. Bonfiglio ... giving the presentation and will join TapImmune management in ...
(Date:11/30/2015)... Florida and MAGDEBURG, Germany , ... of NeuroRehabilitation (ECNR) in Vienna, Austria ... 3rd European Congress of NeuroRehabilitation (ECNR) in ... --> NovaVision, a wholly owned subsidiary of Vycor ... European version of its Internet-delivered NovaVision Therapy Suite at the ...
Breaking Biology Technology: